Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
08/2005
08/04/2005US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649809A Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/02/2005US6924396 α-haloenamine reagents
07/2005
07/28/2005WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068415A1 Phenylalanine derivative
07/28/2005WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses
07/28/2005US20050165259 Cannabinoids
07/28/2005US20050165021 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
07/28/2005US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
07/27/2005EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases
07/27/2005EP0973705B1 Chromatographic enantiomer separation of lactones
07/27/2005CN1646517A Process for the preparation of 4-oxytetrahydropyran-2-ones
07/27/2005CN1646484A Lactic acid derivative
07/27/2005CN1646463A Multifunctional monomers and their use in making cross-linked polymers and porous films
07/27/2005CN1646426A Metallized mesoporous silicate and method of oxidation with the same
07/21/2005WO2005066159A1 Cathepsin cysteine protease inhibitors
07/21/2005WO2005066150A1 A novel process for the preparation of simvastatin
07/21/2005WO2004050609A8 Substituted ureas and carbamates
07/21/2005US20050159615 Process for preparation of statins with high syn to anti ratio
07/21/2005US20050159480 Preparation of statins by reacting (trisubstituted phosphoranylidenecarbonyl)acetates with benzaldehydes, reduction with diamino-group 8 metal coordinates, condensation with 1-hydroxy-1-alkoxyethylenes, hydrolysis, and optionally converting the carboxy acid product into a salt or a lactone
07/21/2005US20050159479 Use of pyrone carboxylates for controlling pests
07/21/2005US20050159449 Cannabinoids
07/21/2005CA2552726A1 Cathepsin cysteine protease inhibitors
07/20/2005EP1555261A1 Valerolactone compounds and perfume composition
07/20/2005EP1555021A1 Combinations of a mevalonate pathway inhibitor and a PPAR-gamma agonist for treating cancer
07/20/2005EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands
07/20/2005EP1056717B1 Arylphenyl-substituted cyclic keto-enols
07/20/2005CN1642932A Anomeric derivatives of monosaccharides
07/20/2005CN1642892A Process for converting alcohols to carbonyl compounds
07/20/2005CN1642555A Statin therapy for enhancing cognitive maintenance
07/20/2005CN1211352C Cyclohexenone oxime ether metal salts
07/19/2005US6919160 Acrylic compounds for sub-200 nm photoresist compositions and methods for making and using same
07/14/2005WO2005063729A1 3-(4-benzyloxyphenyl)propanoic acid derivatives
07/14/2005WO2005063728A2 Process for preparation of statins with high syn to anti ratio
07/14/2005WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
07/14/2005WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005062748A2 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
07/14/2005US20050155087 Method of screening compounds
07/14/2005US20050154062 Substituted chiral allosteric hemoglobin modifiers
07/14/2005US20050153958 Substituted aryl ketones
07/14/2005CA2645396A1 Process for preparation of statins with high syn to anti ratio
07/14/2005CA2551610A1 3-(4-benzyloxyphenyl)propanoic acid derivatives
07/14/2005CA2550742A1 Process for preparation of statins with high syn to anti ratio
07/14/2005CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/13/2005EP1553451A1 Photoresist base material, method for purification thereof, and photoresist compositions
07/13/2005EP1553094A1 Azulene derivatives and salts thereof
07/13/2005EP1553092A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
07/13/2005EP1551805A1 Substituted gamma-phenyl-delta-lactams and uses related thereto
07/13/2005EP1551228A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
07/13/2005EP1373548B1 Chemo-enzymatic synthesis of optically enriched rose-oxides
07/13/2005CN1639154A Pyranones useful as ATM inhibitors
07/13/2005CN1636983A Substituted heterocyclic compounds
07/13/2005CN1210271C Improved method for producing unsaturated cyclic ethers
07/13/2005CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
07/13/2005CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
07/13/2005CN1210257C Substituted aromatic-ring compounds, process for producing the same, and and use thereof
07/13/2005CN1210250C Benzene derivatives, preparation method and pharmaceutical compositions containing same
07/12/2005US6916847 Anticoagulants; thrombosis; cardiovascular disorders
07/07/2005WO2005061479A1 Processes for producing tetrahydropyran-4-one and pyran-4-one
07/07/2005WO2005061478A1 Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid
07/07/2005WO2005061448A1 Compositions and methods for treating vascular conditions
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
07/07/2005US20050148785 Process for the preparation of 2-(6-substituted-1,-3-dioxane-4-YL) acetic acid derivatives
07/07/2005US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment
07/07/2005US20050148549 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
07/07/2005CA2548442A1 Benzoyl-substituted phenylalanine amides
07/06/2005EP1549600A1 Ketones
07/06/2005CN1636004A Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
07/06/2005CN1634908A Process for synthesis of (3R, 5R)-3-hydroxy-5-amino ethyl cyclo-valerolactone
06/2005
06/30/2005WO2005058861A1 Process for preparing simvastatin.
06/30/2005WO2005058860A1 Process for producing 4-(un)substituted tetrahyropyran-4-carboxylic acid compound or ester compound thereof
06/30/2005WO2005058859A1 Processes for producing alkyl 3-(4-tetrahydropyranyl)-3-oxopropionate compound and 4-acyltetrahydropyran
06/30/2005WO2005058812A2 Prostaglandin synthesis
06/30/2005WO2005016277A3 Arylsulfonamidobenzylic compounds
06/30/2005WO2004089926A3 Genipin derivatives and uses thereof
06/30/2005US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders
06/30/2005US20050142300 Tetrahydropyran derivatives having at least one ester group; electrooptical display device; for example, 2-(p-(3,4,5-trifluorophenyloxycarbonyl)phenyl)-5-ethyl-tetrahydropyran; positive dielectric anisotropy; chemical stability
06/30/2005CA2854783A1 Prostaglandin synthesis
06/30/2005CA2549056A1 Prostaglandin synthesis
06/29/2005EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs
06/29/2005CN1633504A Method of preparing 3-[2-{(methylsulfonyl)oxy}ethoxy]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
06/29/2005CN1631879A Substituted phenyl keto enols as pesticides and herbicides
06/29/2005CN1631878A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
06/29/2005CN1208066C Use of cyclic ether for preparation of medicaments affecting glucose tolerance
06/28/2005CA2168097C Substituted 2-aminotetralins
06/23/2005WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof
06/23/2005US20050137211 Phenyl-piperazine derivatives as modulators of muscarinic receptors
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 129